A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera

Primary Objective

To evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera in maintaining hematocrit control.

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

University of Colorado Hospital

Principal Investigator
Photograph of Brandon Mcmahon,  MD

Brandon Mcmahon, MD

Study ID

Protocol Number: 22-0305

More information available at ClinicalTrials.gov: NCT05210790

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers